![](/img/cover-not-exists.png)
Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
Coiffier, B., Pro, B., Prince, H. M., Foss, F., Sokol, L., Greenwood, M., Caballero, D., Borchmann, P., Morschhauser, F., Wilhelm, M., Pinter-Brown, L., Padmanabhan, S., Shustov, A., Nichols, J., CarrVolume:
30
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2011.37.4223
Date:
February, 2012
File:
PDF, 112 KB
english, 2012